SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-16-013330
Filing Date
2016-11-09
Accepted
2016-11-09 17:14:18
Documents
52
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nbio_10q.htm 10-Q 200733
2 CERTIFICATION nbio_ex311.htm EX-31.1 9490
3 CERTIFICATION nbio_ex312.htm EX-31.2 8048
4 CERTIFICATION nbio_ex321.htm EX-32.1 3466
5 CERTIFICATION nbio_ex322.htm EX-32.2 3526
  Complete submission text file 0001477932-16-013330.txt   1709857

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nbio-20160930.xml EX-101.INS 297709
7 XBRL TAXONOMY EXTENSION SCHEMA nbio-20160930.xsd EX-101.SCH 31528
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20160930_cal.xml EX-101.CAL 31300
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20160930_def.xml EX-101.DEF 42316
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20160930_lab.xml EX-101.LAB 155651
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20160930_pre.xml EX-101.PRE 124667
Mailing Address 601 21ST STREET SUITE 300 VERO BEACH FL 32960
Business Address 601 21ST STREET SUITE 300 VERO BEACH FL 32960 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55299 | Film No.: 161985149
SIC: 2834 Pharmaceutical Preparations